{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:46:31Z","timestamp":1793047591214,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00228-025-03989-2","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:13:51Z","timestamp":1768806831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Systematic review and meta-analysis of AI accuracy in warfarin dose prediction across ethnic groups"],"prefix":"10.1007","volume":"82","author":[{"given":"Bassel","family":"Alrabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Marouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq","family":"Bashaireh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alhumam","family":"Alqudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamen","family":"Refai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Bandak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"3989_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.7326\/0003-4819-121-9-199411010-00009","volume":"121","author":"PS Wells","year":"1994","unstructured":"Wells PS, Holbrook AM, Crowther NR, Hirsh J (1994) Interactions of warfarin with drugs and food. Ann Intern Med 121:676\u2013683. https:\/\/doi.org\/10.7326\/0003-4819-121-9-199411010-00009","journal-title":"Ann Intern Med"},{"key":"3989_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11096-022-01386-8","volume":"44","author":"AM Fahmi","year":"2022","unstructured":"Fahmi AM, Elewa H, El Jilany I (2022) Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative review. Int J Clin Pharm 44:599\u2013607. https:\/\/doi.org\/10.1007\/s11096-022-01386-8","journal-title":"Int J Clin Pharm"},{"key":"3989_CR3","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/archinte.167.13.1414","volume":"167","author":"DK Wysowski","year":"2007","unstructured":"Wysowski DK, Nourjah P, Swartz L (2007) Bleeding complications with warfarin use. Arch Intern Med 167:1414. https:\/\/doi.org\/10.1001\/archinte.167.13.1414","journal-title":"Arch Intern Med"},{"key":"3989_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.5830\/CVJA-2017-029","volume":"28","author":"A Jacobs","year":"2017","unstructured":"Jacobs A, Bassa F, Decloedt EH (2017) A preliminary review of warfarin toxicity in a tertiary hospital in Cape Town, South Africa. Cardiovasc J Afr 28:346\u2013349. https:\/\/doi.org\/10.5830\/CVJA-2017-029","journal-title":"Cardiovasc J Afr"},{"key":"3989_CR5","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1310\/hpj4911-1044","volume":"49","author":"N Pourdeyhimi","year":"2014","unstructured":"Pourdeyhimi N, Bullard Z (2014) Warfarin-induced skin necrosis. Hosp Pharm 49:1044\u20131048. https:\/\/doi.org\/10.1310\/hpj4911-1044","journal-title":"Hosp Pharm"},{"key":"3989_CR6","doi-asserted-by":"publisher","first-page":"e12249","DOI":"10.7759\/cureus.12249","volume":"12","author":"FH Abutaki","year":"2020","unstructured":"Abutaki FH, Alfaraj D, Alshahrani A, Elsharkawy T (2020) Warfarin-Induced calciphylaxis in a COVID-19 patient. Cureus 12:e12249. https:\/\/doi.org\/10.7759\/cureus.12249","journal-title":"Cureus"},{"key":"3989_CR7","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1253\/circj.CJ-17-1110","volume":"82","author":"Y Sakamoto","year":"2018","unstructured":"Sakamoto Y, Okubo S, Nito C et al (2018) Insufficient warfarin therapy is associated with higher severity of stroke than no anticoagulation in patients with atrial fibrillation and acute anterior-circulation stroke. Circ J 82:1437\u20131442. https:\/\/doi.org\/10.1253\/circj.CJ-17-1110","journal-title":"Circ J"},{"key":"3989_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1445-5994.1991.tb04697.x","volume":"21","author":"CJ Doecke","year":"1991","unstructured":"Doecke CJ, Cosh DG, Gallus AS (1991) Standardised initial warfarin treatment: evaluation of initial treatment response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin response. Aust N Z J Med 21:319\u2013324. https:\/\/doi.org\/10.1111\/j.1445-5994.1991.tb04697.x","journal-title":"Aust N Z J Med"},{"key":"3989_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00439-006-0260-8","volume":"121","author":"M Wadelius","year":"2007","unstructured":"Wadelius M, Chen LY, Eriksson N et al (2007) Association of warfarin dose with genes involved in its action and metabolism. Hum Genet 121:23\u201334. https:\/\/doi.org\/10.1007\/s00439-006-0260-8","journal-title":"Hum Genet"},{"key":"3989_CR10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1182\/blood-2011-08-372722","volume":"119","author":"TT Biss","year":"2012","unstructured":"Biss TT, Avery PJ, Brand\u00e3o LR et al (2012) VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children. Blood 119:868\u2013873. https:\/\/doi.org\/10.1182\/blood-2011-08-372722","journal-title":"Blood"},{"key":"3989_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12916-018-1093-8","volume":"16","author":"NL Syn","year":"2018","unstructured":"Syn NL, Wong AL-A, Lee S-C et al (2018) Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial. BMC Med 16:104. https:\/\/doi.org\/10.1186\/s12916-018-1093-8","journal-title":"BMC Med"},{"key":"3989_CR12","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s00277-024-05757-1","volume":"103","author":"A Anand","year":"2024","unstructured":"Anand A, Hegde NC, Chhabra P et al (2024) Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial. Ann Hematol 103:2133\u20132144. https:\/\/doi.org\/10.1007\/s00277-024-05757-1","journal-title":"Ann Hematol"},{"key":"3989_CR13","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1111\/bcp.13621","volume":"84","author":"G Tse","year":"2018","unstructured":"Tse G, Gong M, Li G et al (2018) Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol 84:1868\u20131882. https:\/\/doi.org\/10.1111\/bcp.13621","journal-title":"Br J Clin Pharmacol"},{"key":"3989_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/cts.12884","volume":"14","author":"KB Johnson","year":"2021","unstructured":"Johnson KB, Wei WQ, Weeraratne D et al (2021) Precision medicine, AI, and the future of personalized health care. Clin Transl Sci 14:86\u201393. https:\/\/doi.org\/10.1111\/cts.12884","journal-title":"Clin Transl Sci"},{"key":"3989_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0135784","volume":"10","author":"R Liu","year":"2015","unstructured":"Liu R, Li X, Zhang W, Zhou HH (2015) Comparison of nine statistical model based warfarin pharmacogenetic dosing algorithms using the Racially diverse international warfarin Pharmacogenetic consortium cohort database. PLoS One 10:1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0135784","journal-title":"PLoS One"},{"key":"3989_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.01550","volume":"10","author":"A Roche-Lima","year":"2020","unstructured":"Roche-Lima A, Roman-Santiago A, Feliu-Maldonado R et al (2020) Machine learning algorithm for predicting warfarin dose in Caribbean Hispanics using Pharmacogenetic data. Front Pharmacol 10:1\u20138. https:\/\/doi.org\/10.3389\/fphar.2019.01550","journal-title":"Front Pharmacol"},{"key":"3989_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijcard.2020.03.055","volume":"317","author":"N Dietz","year":"2020","unstructured":"Dietz N, Ruff C, Giugliano RP et al (2020) Pharmacogenetic-guided and clinical warfarin dosing algorithm assessments with bleeding outcomes risk-stratified by genetic and covariate subgroups. Int J Cardiol 317:159\u2013166. https:\/\/doi.org\/10.1016\/j.ijcard.2020.03.055","journal-title":"Int J Cardiol"},{"key":"3989_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11096-022-01471-y","volume":"45","author":"K Sridharan","year":"2023","unstructured":"Sridharan K, Ramanathan M, Al Banna R (2023) Evaluation of supervised machine learning algorithms in predicting the poor anticoagulation control and stable weekly doses of warfarin. Int J Clin Pharm 45:79\u201387. https:\/\/doi.org\/10.1007\/s11096-022-01471-y","journal-title":"Int J Clin Pharm"},{"key":"3989_CR19","doi-asserted-by":"publisher","first-page":"106589","DOI":"10.1016\/j.cmpb.2021.106589","volume":"214","author":"R Maghsoudi","year":"2022","unstructured":"Maghsoudi R, Mirzarezaee M, Sadeghi M, Nadjar-Araabi B (2022) Determining the adjusted initial treatment dose of warfarin anticoagulant medicine using kernel-based support vector regression. Comput Methods Programs Biomed 214:106589. https:\/\/doi.org\/10.1016\/j.cmpb.2021.106589","journal-title":"Comput Methods Programs Biomed"},{"key":"3989_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I 2 index? Psychol Methods 11:193\u2013206. https:\/\/doi.org\/10.1037\/1082-989X.11.2.193","journal-title":"Psychol Methods"},{"key":"3989_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"RF Wolff","year":"2019","unstructured":"Wolff RF, Moons KGM, Riley RD et al (2019) PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med 170:51\u201358. https:\/\/doi.org\/10.7326\/M18-1376","journal-title":"Ann Intern Med"},{"key":"3989_CR22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/cpt.2407","volume":"110","author":"Q Huang","year":"2021","unstructured":"Huang Q, Cao L, Luo N et al (2021) Predicting range of initial warfarin dose based on pharmacometabolomic and genetic inputs. Clin Pharmacol Ther 110:1585\u20131594. https:\/\/doi.org\/10.1002\/cpt.2407","journal-title":"Clin Pharmacol Ther"},{"key":"3989_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1109\/JBHI.2018.2812165","volume":"23","author":"Y Tao","year":"2019","unstructured":"Tao Y, Chen YJ, Fu X et al (2019) Evolutionary ensemble learning algorithm to modeling of warfarin dose prediction for Chinese. IEEE J Biomed Health Inform 23:395\u2013406. https:\/\/doi.org\/10.1109\/JBHI.2018.2812165","journal-title":"IEEE J Biomed Health Inform"},{"key":"3989_CR24","unstructured":"Zeyuan Wang, Josiah Poon, Jie Yang SP. Warfarin dose estimation on high-dimensional and incomplete data"},{"key":"3989_CR25","unstructured":"Xi Li\u2021, 1, 2, Rong Liu\u2021, 1, 2, Zhi-Ying Luo1 2,, Han Yan1 2, Wei-Hua et al (2015) Comparison of the predictive abilities of pharmacogenetics-based warfarin dosing algorithms using seven mathematical models in Chinese patients, pp 11\u201313"},{"key":"3989_CR26","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1109\/JBHI.2019.2891164","volume":"23","author":"Y Tao","year":"2019","unstructured":"Tao Y, Chen YJ, Xue L et al (2019) An ensemble model with clustering assumption for warfarin dose prediction in Chinese patients. IEEE J Biomed Health Inform 23:2642\u20132654. https:\/\/doi.org\/10.1109\/JBHI.2019.2891164","journal-title":"IEEE J Biomed Health Inform"},{"key":"3989_CR27","doi-asserted-by":"crossref","unstructured":"Yuzhen YT (2018) WarfarinSeer: a predictive tool based on SMOTE-random forest to improve warfarin dose prediction in Chinese patients. IEEE Int Conf Bioinforma Biomed 6027:1022\u20131026","DOI":"10.1109\/BIBM.2018.8621203"},{"key":"3989_CR28","unstructured":"V Jahmunah1, Sylvia Chen2, Shu Lih Oh1, U Rajendra Acharya1,3,4,5,6*, Balram Chowbay 2,7 8* 1 (2019) Automated warfarin dose prediction for Asian, American, and Caucasian populations using a deep neural network 9655827:1\u201326"},{"key":"3989_CR29","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/jth.15318","volume":"19","author":"VL Nguyen","year":"2021","unstructured":"Nguyen VL, Nguyen HD, Cho YS et al (2021) Comparison of multivariate linear regression and a machine learning algorithm developed for prediction of precision warfarin dosing in a Korean population. J Thromb Haemost 19:1676\u20131686. https:\/\/doi.org\/10.1111\/jth.15318","journal-title":"J Thromb Haemost"},{"key":"3989_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/FJC.0000000000000317","volume":"67","author":"S Alzubiedi","year":"2016","unstructured":"Alzubiedi S, Saleh MI (2016) Pharmacogenetic-guided warfarin dosing algorithm in African-Americans. J Cardiovasc Pharmacol 67:86\u201392. https:\/\/doi.org\/10.1097\/FJC.0000000000000317","journal-title":"J Cardiovasc Pharmacol"},{"key":"3989_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2021.749786","volume":"12","author":"HE Steiner","year":"2021","unstructured":"Steiner HE, Giles JB, Patterson HK et al (2021) Machine learning for prediction of stable warfarin dose in US Latinos and Latin Americans. Front Pharmacol 12:1\u201313. https:\/\/doi.org\/10.3389\/fphar.2021.749786","journal-title":"Front Pharmacol"},{"key":"3989_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0205872","volume":"13","author":"Z Ma","year":"2018","unstructured":"Ma Z, Wang P, Gao Z et al (2018) Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose. PLoS ONE 13:1\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0205872","journal-title":"PLoS ONE"},{"key":"3989_CR33","doi-asserted-by":"publisher","first-page":"103634","DOI":"10.1016\/j.jbi.2020.103634","volume":"113","author":"G Truda","year":"2021","unstructured":"Truda G, Marais P (2021) Evaluating warfarin dosing models on multiple datasets with a novel software framework and evolutionary optimisation. J Biomed Inform 113:103634. https:\/\/doi.org\/10.1016\/j.jbi.2020.103634","journal-title":"J Biomed Inform"},{"key":"3989_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-020-00781-2","volume":"13","author":"Y Tao","year":"2020","unstructured":"Tao Y, Zhang Y, Jiang B (2020) Dbcsmote: a clustering-based oversampling technique for data-imbalanced warfarin dose prediction. BMC Med Genomics 13:1\u201313. https:\/\/doi.org\/10.1186\/s12920-020-00781-2","journal-title":"BMC Med Genomics"},{"key":"3989_CR35","doi-asserted-by":"publisher","unstructured":"Susanne Rosth\u00f8j1,\u2021 Catherine Fullwood2, \u00a7, Robin Henderson3,\u2217,\u2020 and Syd Stewart4 \u00b6 (2008) Estimation of optimal dynamic anticoagulation regimes from observational data: a regret-based approach 4267\u20134278. https:\/\/doi.org\/10.1002\/sim","DOI":"10.1002\/sim"},{"key":"3989_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/hep.30150.Ductular","volume":"176","author":"Kaye Justin B","year":"2017","unstructured":"Justin B Kaye, Lauren E Schultz, Heidi E Steiner, Rick A Kittles, Larisa H Cavallari, Jason H Karnes (2017) WARFARIN PHARMACOGENOMICS IN DIVERSE POPULATIONS. Physiol Behav 176:139\u2013148. https:\/\/doi.org\/10.1002\/hep.30150.Ductular","journal-title":"Physiol Behav"},{"key":"3989_CR37","unstructured":"Dean L (2012) Warfarin therapy and VKORC1 and CYP genotype. Med Genet Summ 1\u201315"},{"key":"3989_CR38","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s11096-023-01565-1","volume":"45","author":"W Gao","year":"2023","unstructured":"Gao W, Zhang Z, Guan Z et al (2023) Developing Chinese race-specific warfarin dose prediction algorithms. Int J Clin Pharm 45:731\u2013738. https:\/\/doi.org\/10.1007\/s11096-023-01565-1","journal-title":"Int J Clin Pharm"},{"key":"3989_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/GIM.0b013e318163c35f","volume":"10","author":"DA Flockhart","year":"2008","unstructured":"Flockhart DA, O\u2019Kane D, Williams MS et al (2008) Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Genet Med 10:139\u2013150. https:\/\/doi.org\/10.1097\/GIM.0b013e318163c35f","journal-title":"Genet Med"},{"key":"3989_CR40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2217\/pgs.10.49","volume":"11","author":"SA Scott","year":"2010","unstructured":"Scott SA, Khasawneh R, Peter I et al (2010) Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups. Pharmacogenomics 11:781\u2013791. https:\/\/doi.org\/10.2217\/pgs.10.49","journal-title":"Pharmacogenomics"},{"key":"3989_CR41","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1055\/s-0032-1328891","volume":"38","author":"E Fung","year":"2012","unstructured":"Fung E, Patsopoulos NA, Belknap SM et al (2012) Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin. Semin Thromb Hemost 38:893\u2013904. https:\/\/doi.org\/10.1055\/s-0032-1328891","journal-title":"Semin Thromb Hemost"},{"key":"3989_CR42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.thromres.2014.05.028","volume":"134","author":"T Gaikwad","year":"2014","unstructured":"Gaikwad T, Ghosh K, Shetty S (2014) VKORC1 and CYP2C9 genotype distribution in Asian countries. Thromb Res 134:537\u2013544. https:\/\/doi.org\/10.1016\/j.thromres.2014.05.028","journal-title":"Thromb Res"},{"key":"3989_CR43","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1111\/jth.15494","volume":"19","author":"A Ndadza","year":"2021","unstructured":"Ndadza A, Muyambo S, Mntla P et al (2021) Profiling of warfarin pharmacokinetics-associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics-dosing algorithm. J Thromb Haemost 19:2957\u20132973. https:\/\/doi.org\/10.1111\/jth.15494","journal-title":"J Thromb Haemost"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03989-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-025-03989-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03989-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:05:12Z","timestamp":1771859112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-025-03989-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3989"],"URL":"https:\/\/doi.org\/10.1007\/s00228-025-03989-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}